China Universal Asset Management Co. Ltd. raised its position in Insmed Incorporated (NASDAQ:INSM – Free Report) by 347.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 16,551 shares of the biopharmaceutical company’s stock after buying an additional 12,853 shares during […]
Shares of Insmed Incorporated (NASDAQ:INSM – Get Free Report) have been given an average recommendation of “Buy” by the ten brokerages that are presently covering the firm, MarketBeat.com reports. Ten research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have issued ratings on the stock in […]
Insmed (NASDAQ:INSM – Get Free Report) issued its earnings results on Thursday. The biopharmaceutical company reported ($1.28) earnings per share for the quarter, missing the consensus estimate of ($1.13) by ($0.15), Briefing.com reports. The firm had revenue of $83.70 million for the quarter, compared to analyst estimates of $82.15 million. During the same quarter in […]
Insmed (NASDAQ:INSM – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Tuesday. A number of other equities research analysts also recently weighed in on INSM. Wolfe Research started coverage on Insmed in a report on Thursday, February 15th. They issued […]
Insmed (NASDAQ:INSM – Get Free Report) will announce its 12/31/2023 earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of ($1.13) per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link. Insmed Trading Down 1.0 % Shares […]